Neuropsychological Testing
Customize your policy alerts
Sign up for all CareFirst policy alerts
Know when CareFirst releases new policies or updates existing guidance.
Monitor payer policy activity
Defines medical necessity and investigational uses of neuropsychological testing for CareFirst members, adopting MCG Care Guidelines for clinical criteria and applicability; affects providers requesting or performing neuropsychological assessments for diagnosis, pre/postoperative evaluation, or rehabilitation planning.
CareFirst has adopted the position of MCG Care Guidelines® Neuropsychological Testing along with its proprietary clinical criteria for medical necessity and clinical appropriateness.
Local detailed criteria in this document are retired in favor of MCG criteria.
Neuropsychological testing is considered medically necessary as outlined in the Policy Guidelines; testing for other conditions is investigational per TEC criteria.
Coverage Criteria
Medically Necessary Indications
Covered when ALL of the following are met (see MCG Care Guidelines for full criteria):
Providers must reference MCG criteria at carefirst.access.mcg.com.
This list is illustrative; authoritative indications are in the adopted MCG criteria.
Experimental / Investigational
Considered experimental/investigational when ALL of the following apply (per BCBSA/TEC criteria assessment):
Assessments do not require regulatory approval; lack of evidence in non-brain-damage settings supports investigational stance.
Benefits are not provided for diagnostic or treatment services related to learning, curriculum planning, educational achievement, or special education programs provided under the Individuals with Disabilities Education Act (IDEA) — including IEP or IFSP — or Section 504 (504 Plan). These educational assessments and related services are the responsibility of the educational system and are excluded from coverage under this policy.
Providers must verify member contract provisions and benefit limitations prior to service; specific contract exclusions, restrictions, or prior authorization requirements take precedence over this clinical policy.
Neuropsychological testing for conditions that do not involve known brain damage or a risk for brain damage is considered experimental/investigational and not covered because current evidence does not demonstrate improved net health outcomes or benefit over alternatives for these indications. The policy applies TEC/BCBSA criteria which require demonstrated benefit, generalizability outside investigational settings, and favorable comparison to established alternatives.
Examples and rationale in the literature review indicate that testing in non–brain-damage situations has not been shown to produce meaningful improvement in outcomes, and therefore such uses fail to meet the evidentiary thresholds required for coverage.
Coding and Time Thresholds
| not specified | No explicit CPT/HCPCS/ICD-10 codes listed in this policy document; examples of test batteries are named but billing codes are not provided. |
Provider Actions and Authorization
Prior Authorization and Benefit Verification
Some services, devices, drugs, and places of service require prior authorization. Always check the member's contract for benefits; specific contract provisions, restrictions, and exclusions take precedence over these clinical criteria. Verify member contract and benefits and obtain prior authorization when required by the member's plan.
- Prior authorization may be required for certain services, places of service, devices, or drugs
- Member contract and benefits override policy clinical criteria
- Verify eligibility and benefits before scheduling services
No Step Therapy Protocols Specified
No step therapy protocols for neuropsychological testing are specified in this policy. Follow any contract-specific prior authorization or utilization management requirements if they exist on the member's plan.
- If the member's contract includes step therapy or other utilization controls, those contract-specific rules apply
- When in doubt, confirm requirements during benefit verification/prior authorization
Documentation Requirement for Extended Testing Time
Typically, the test battery will require up to 8 hours to perform, including administration, scoring and interpretation. If total testing time exceeds 8 hours, submit documentation indicating the medical necessity for the extended testing time; such documentation may be requested during review.
- Typical total testing time: up to 8 hours (administration, scoring, interpretation)
- If testing exceeds 8 hours, provide supporting documentation of medical necessity
Requests Not Meeting Policy Guidelines
Requests that do not meet the Policy Guidelines or the contract-specific coverage criteria may be considered investigational or denied. Ensure submitted requests include documentation that demonstrates medical necessity per the Policy Guidelines and applicable contract terms.
- Services not meeting Policy Guidelines may be deemed experimental/investigational and are subject to denial risk
- Include sufficient clinical documentation to support medical necessity per policy and member contract
Background
Neuropsychological testing is a battery-based assessment of cognitive functions — including memory, intellectual ability, perceptual-motor skills, language, and behavior — administered with standardized instruments and interpreted by qualified clinicians. Testing is typically used to identify cognitive deficits, assist differential diagnosis between neurogenic and psychogenic syndromes, inform prognosis, and guide rehabilitation or surgical planning (for example, pre- and post–epilepsy surgery evaluation).
Typical test batteries include instruments such as the Halstead-Reitan, WAIS-IV, WMS-IV, Luria-Nebraska, and Wisconsin Card Sorting Test. Results are documented in a written report. CareFirst has adopted the MCG Care Guidelines® for specific medical necessity criteria, and this local policy has been retired in favor of the MCG guidance.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.